Europäische Marktprognose für Rückenmarkstimulationsgeräte gegen chronische Schmerzen bis 2030 – Regionale Analyse – nach Produkttyp (wiederaufladbar und nicht wiederaufladbar), Anwendung (Failed-Back-Syndrom, komplexes regionales Schmerzsyndrom, degenerative Bandscheibenerkrankung und andere) und Endnutzer (Krankenhäuser, ambulante Operationszentren und andere)

BMIRE00030432 | Pages: 157 | Medical Device | Jul 2024 | Type: Regional | Status: Published
Der Markt für Rückenmarkstimulationsgeräte gegen chronische Schmerzen wurde im Jahr 2022 auf 799,87 Millionen US-Dollar geschätzt und soll bis 2030 1.412,01 Millionen US-Dollar erreichen; von 2022 bis 2030 wird eine durchschnittliche jährliche Wachstumsrate von 7,4 % erwartet.

Rehabilitation und spezialisierte Zentren, die eine wirksame Behandlung von Rückenmarksverletzungen anbieten, beflügeln den Markt für Rückenmarkstimulationsgeräte gegen chronische Schmerzen

Laut einem Bericht des NIH wurden in England erstmals spezialisierte Behandlungszentren für Rückenmarksverletzungen eingerichtet, um die Versorgung und neurologische Genesung der Patienten zu verbessern. Zentren der tertiären Behandlung von Rückenmarksverletzungen werden entwickelt, um die klinischen Ergebnisse und die neurologische Genesung von Patienten mit akuten Rückenmarksverletzungen zu verbessern. Darüber hinaus ist das Zentrum für Rückenmarksverletzungen am Universitätsklinikum Heidelberg in Deutschland das einzige akademische Zentrum, das sich der Behandlung und Erforschung von Rückenmarksverletzungen widmet. Das Personal des Universitätsklinikums Heidelberg, darunter etwa 145 Mitarbeiter, behandelt jährlich etwa 1.500 Patienten mit akuten oder chronischen Rückenmarksverletzungen, von denen 1.000 ambulant behandelt werden.

Geräte zur Rückenmarksstimulation werden in Rehabilitationszentren häufig eingesetzt. Eine auf diesen Geräten basierende Behandlungsmethode unterstützt Patienten physisch und psychisch, um ihre neurologische Genesung und allgemeine Gesundheit in kurzer Zeit zu maximieren. Das Walk Again Center in Berlin ist ein Beispiel für ein Rehabilitationszentrum zur Behandlung neurologischer Erkrankungen. Dieses Rehabilitationszentrum setzt sowohl Medizin als auch Technologie zur Behandlung von Rückenmarksverletzungen ein. Es verwendet innovative medizinische Verfahren, darunter strukturelle und neuronale Neuroplastizität, bei denen Ärzte Patienten mit Hirnschäden therapieren. Daher bieten fortschrittliche Rehabilitationszentren und spezialisierte Zentren Wachstumschancen für den europäischen Markt für Geräte zur Rückenmarksstimulation bei chronischen Schmerzen.

Überblick über den europäischen Markt für Geräte zur Rückenmarksstimulation bei chronischen Schmerzen

Der europäische Markt für Geräte zur Rückenmarksstimulation bei chronischen Schmerzen ist nach Regionen unterteilt in Deutschland, Frankreich, Italien, Spanien, Großbritannien, Schweiz, Niederlande, Schweden und Restliches Europa. Steigende Gesundheitsansprüche und die damit verbundenen Kosten, zunehmende Verwaltungstransaktionen und die Plattform für Rückenmarksstimulationsgeräte zur Verfolgung der Lieferkette sind einige der wichtigsten Faktoren, die das Marktwachstum vorantreiben. In Italien beispielsweise werden Rückenmarksbehandlungen in Krankenhäusern vollständig durch die Versicherung des italienischen nationalen Gesundheitssystems (NHS) übernommen. Daher ist das Bewusstsein für wirksame Behandlungen von Rückenmarksverletzungen in der italienischen Bevölkerung hoch. Die Verfügbarkeit angemessener Krankenversicherungsleistungen für Rückenmarksverletzungen bedeutet daher eine hohe Nachfrage nach Rückenmarksstimulationsgeräten in den Krankenhäusern und Fachzentren Italiens.

Umsatz und Prognose des europäischen Marktes für Rückenmarksstimulationsgeräte gegen chronische Schmerzen bis 2030 (in Millionen US-Dollar)

Segmentierung des europäischen Marktes für Rückenmarksstimulationsgeräte gegen chronische Schmerzen

Der Markt für Rückenmarksstimulationsgeräte gegen chronische Schmerzen ist nach Produkttyp, Anwendung, Endbenutzer und Land segmentiert.

Basierend auf dem Produkttyp ist der Markt für Rückenmarksstimulationsgeräte gegen chronische Schmerzen in wiederaufladbare und nicht wiederaufladbare Geräte unterteilt. Das wiederaufladbare Segment hatte 2022 einen größeren Anteil.

In Bezug auf die Anwendung ist der Markt für Rückenmarkstimulationsgeräte für chronische Schmerzen in Failed-Back-Syndrom, komplexes regionales Schmerzsyndrom, degenerative Bandscheibenerkrankung und andere unterteilt. Das Segment des komplexen regionalen Schmerzsyndroms hatte 2022 den größten Anteil.

Nach Endbenutzer ist der Markt für Rückenmarkstimulationsgeräte für chronische Schmerzen in Krankenhäuser, ambulante Operationszentren (ASCS) und andere unterteilt. Das Krankenhaussegment hatte 2022 den größten Anteil.

Nach Ländern ist der Markt für Rückenmarkstimulationsgeräte für chronische Schmerzen in Deutschland, Frankreich, Großbritannien, Spanien, Italien, Schweiz, Schweden, Polen, Belgien, Slowakei, Tschechische Republik, Griechenland, Irland, Niederlande und Restliches Europa unterteilt. Deutschland dominierte im Jahr 2022 den Markt für Geräte zur Rückenmarksstimulation gegen chronische Schmerzen.

Boston Scientific Corp, Abbott Laboratories, Medtronic Plc, Biotronik SE & Co KG, Nevro Corp, Cirtec Medical Corp und Synapse Biomedical Inc sind einige der führenden Unternehmen auf dem europäischen Markt für Geräte zur Rückenmarksstimulation gegen chronische Schmerzen.

TABLE OF CONTENTS

 

1. Introduction

1.1 The Insight Partners Research Report Guidance

1.2 Market Segmentation

1.2.1 Europe Spinal Cord Stimulation Device for Chronic Pain Market - by Product Type

1.2.2 Europe Spinal Cord Stimulation Device for Chronic Pain Market - by Application

1.2.3 Europe Spinal Cord Stimulation Device for Chronic Pain Market - by End User

1.2.4 Europe Spinal Cord Stimulation Device for Chronic Pain Market - by Country

2. Europe Spinal Cord Stimulation Device for Chronic Pain Market - Key Takeaways

3. Research Methodology

3.1 Coverage

3.2 Secondary Research

3.3 Primary Research

4. Europe Spinal Cord Stimulation Device for Chronic Pain Market - Market Landscape

4.1 Company Share Analysis

4.2 Pricing Analysis

5. Europe Spinal Cord Stimulation Device for Chronic Pain Market

5.1 Market Drivers

5.1.1 Rising Number of Spinal Cord Injuries

5.1.2 Availability of Innovative Treatments in European Union

5.2 Market Restraints

5.2.1 Product Recalls

5.3 Market Opportunities

5.3.1 Rehabilitation and Specialized Centers Providing Effective Treatment for Spinal Cord Injuries

5.4 Future Trends

5.4.1 Regenerative and Innovative Implant-Based Therapeutic Approaches

5.5 Impact analysis

6. Spinal Cord Stimulation Device for Chronic Pain Market - Europe Analysis

6.1 Europe Spinal Cord Stimulation Device for Chronic Pain Market Revenue Forecast and Analysis

7. Europe Spinal Cord Stimulation Device for Chronic Pain Market - Revenue and Forecast to 2030 - by Product Type

7.1 Overview

7.2 Europe Spinal Cord Stimulation Device for Chronic Pain Market Revenue Share, by Product Type, 2022 & 2030 (%)

7.3 Rechargeable

7.3.1 Overview

7.3.2 Rechargeable: Europe Spinal Cord Stimulation Device for Chronic Pain Market - Revenue and Forecast to 2030 (US$ Million)

7.4 Non-Rechargeable

7.4.1 Overview

7.4.2 Non-Rechargeable: Europe Spinal Cord Stimulation Device for Chronic Pain Market - Revenue and Forecast to 2030 (US$ Million)

8. Europe Spinal Cord Stimulation Device for Chronic Pain Market Revenue and Forecasts to 2030- by Application

8.1 Overview

8.1.1 Europe Spinal Cord Stimulation Device for Chronic Pain Market Revenue Share, by Application (2022 and 2030)

8.2 Failed Back Syndrome

8.2.1 Overview

8.2.2 Failed Back Syndrome: Europe Spinal Cord Stimulation Device for Chronic Pain Market- Revenue and Forecast to 2030 (US$ Million)

8.3 Complex Regional Pain Syndrome

8.3.1 Overview

8.3.2 Complex Regional Pain Syndrome: Europe Spinal Cord Stimulation Device for Chronic Pain Market - Revenue and Forecast to 2030 (US$ Million)

8.4 Degenerative Disk Disease

8.4.1 Overview

8.4.2 Degenerative Disk Disease: Europe Spinal Cord Stimulation Device for Chronic Pain Market - Revenue and Forecast to 2030 (US$ Million)

8.5 Others

8.5.1 Overview

8.5.2 Others: Europe Spinal Cord Stimulation Device for Chronic Pain Market - Revenue and Forecast to 2030 (US$ Million)

9. Europe Spinal Cord Stimulation Device for Chronic Pain Market Revenue and Forecasts to 2030- by End User

9.1 Overview

9.2 Europe Spinal Cord Stimulation Device for Chronic Pain Market Revenue Share, by End User (2022 and 2030)

9.3 Hospitals

9.3.1 Overview

9.3.2 Hospitals: Europe Spinal Cord Stimulation Device for Chronic Pain Market- Revenue and Forecast to 2030 (US$ Million)

9.4 Ambulatory Surgery Centers (ASCs)

9.4.1 Overview

9.4.2 Ambulatory Surgery Centers (ASCs): Europe Spinal Cord Stimulation Device for Chronic Pain Market - Revenue and Forecast to 2030 (US$ Million)

9.5 Others

9.5.1 Overview

9.5.2 Others: Europe Spinal Cord Stimulation Device for Chronic Pain Market - Revenue and Forecast to 2030 (US$ Million)

10. Europe Spinal Cord Stimulation Device for Chronic Pain Market - Revenue and Forecast to 2030 -Country Analysis

10.1 Europe Spinal Cord Stimulation Device for Chronic Pain Market, Revenue and Forecast to 2030

10.1.1 Overview

10.1.1.1 Europe: Spinal Cord Stimulation Device for Chronic Pain Market, by Countries

10.1.1.2 Germany

10.1.1.2.1 Overview

10.1.1.2.2 Germany: Spinal Cord Stimulation Device for Chronic Pain Market Revenue and Forecast to 2030 (US$ Mn)

10.1.1.2.3 Germany: Spinal Cord Stimulation Device for Chronic Pain Market, by Product Type

10.1.1.2.4 Germany: Spinal Cord Stimulation Device for Chronic Pain Market, by Application

10.1.1.2.5 Germany: Spinal Cord Stimulation Device for Chronic Pain Market, by End User

10.1.1.3 France

10.1.1.3.1 Overview

10.1.1.3.2 France: Spinal Cord Stimulation Device for Chronic Pain Market Revenue and Forecast to 2030 (US$ Mn)

10.1.1.3.3 France: Spinal Cord Stimulation Device for Chronic Pain Market, by Product Type

10.1.1.3.4 France: Spinal Cord Stimulation Device for Chronic Pain Market, by Application

10.1.1.3.5 France: Spinal Cord Stimulation Device for Chronic Pain Market, by End User

10.1.1.4 Italy

10.1.1.4.1 Overview

10.1.1.4.2 Italy: Spinal Cord Stimulation Device for Chronic Pain Market Revenue and Forecast to 2030 (US$ Mn)

10.1.1.4.3 Italy: Spinal Cord Stimulation Device for Chronic Pain Market, by Product Type

10.1.1.4.4 Italy: Spinal Cord Stimulation Device for Chronic Pain Market, by Application

10.1.1.4.5 Italy: Spinal Cord Stimulation Device for Chronic Pain Market, by End User

10.1.1.5 Spain

10.1.1.5.1 Overview

10.1.1.5.2 Spain: Spinal Cord Stimulation Device for Chronic Pain Market Revenue and Forecast to 2030 (US$ Mn)

10.1.1.5.3 Spain: Spinal Cord Stimulation Device for Chronic Pain Market, by Product Type

10.1.1.5.4 Spain: Spinal Cord Stimulation Device for Chronic Pain Market, by Application

10.1.1.5.5 Spain: Spinal Cord Stimulation Device for Chronic Pain Market, by End User

10.1.1.6 United Kingdom

10.1.1.6.1 Overview

10.1.1.6.2 United Kingdom: Spinal Cord Stimulation Device for Chronic Pain Market Revenue and Forecast to 2030 (US$ Mn)

10.1.1.6.3 United Kingdom: Spinal Cord Stimulation Device for Chronic Pain Market, by Product Type

10.1.1.6.4 United Kingdom: Spinal Cord Stimulation Device for Chronic Pain Market, by Application

10.1.1.6.5 United Kingdom: Spinal Cord Stimulation Device for Chronic Pain Market, by End User

10.1.1.7 Switzerland

10.1.1.7.1 Overview

10.1.1.7.2 Switzerland: Spinal Cord Stimulation Device for Chronic Pain Market Revenue and Forecast to 2030 (US$ Mn)

10.1.1.7.3 Switzerland: Spinal Cord Stimulation Device for Chronic Pain Market, by Product Type

10.1.1.7.4 Switzerland: Spinal Cord Stimulation Device for Chronic Pain Market, by Application

10.1.1.7.5 Switzerland: Spinal Cord Stimulation Device for Chronic Pain Market, by End User

10.1.1.8 Netherlands

10.1.1.8.1 Overview

10.1.1.8.2 Netherlands: Spinal Cord Stimulation Device for Chronic Pain Market Revenue and Forecast to 2030 (US$ Mn)

10.1.1.8.3 Netherlands: Spinal Cord Stimulation Device for Chronic Pain Market, by Product Type

10.1.1.8.4 Netherlands: Spinal Cord Stimulation Device for Chronic Pain Market, by Application

10.1.1.8.5 Netherlands: Spinal Cord Stimulation Device for Chronic Pain Market, by End User

10.1.1.9 Sweden

10.1.1.9.1 Overview

10.1.1.9.2 Sweden: Spinal Cord Stimulation Device for Chronic Pain Market Revenue and Forecast to 2030 (US$ Mn)

10.1.1.9.3 Sweden: Spinal Cord Stimulation Device for Chronic Pain Market, by Product Type

10.1.1.9.4 Sweden: Spinal Cord Stimulation Device for Chronic Pain Market, by Application

10.1.1.9.5 Sweden: Spinal Cord Stimulation Device for Chronic Pain Market, by End User

10.1.1.10 Belgium

10.1.1.10.1 Overview

10.1.1.10.2 Belgium: Spinal Cord Stimulation Device for Chronic Pain Market Revenue and Forecast to 2030 (US$ Mn)

10.1.1.10.3 Belgium: Spinal Cord Stimulation Device for Chronic Pain Market, by Product Type

10.1.1.10.4 Belgium: Spinal Cord Stimulation Device for Chronic Pain Market, by Application

10.1.1.10.5 Belgium: Spinal Cord Stimulation Device for Chronic Pain Market, by End User

10.1.1.11 Poland

10.1.1.11.1 Overview

10.1.1.11.2 Poland: Spinal Cord Stimulation Device for Chronic Pain Market Revenue and Forecast to 2030 (US$ Mn)

10.1.1.11.3 Poland: Spinal Cord Stimulation Device for Chronic Pain Market, by Product Type

10.1.1.11.4 Poland: Spinal Cord Stimulation Device for Chronic Pain Market, by Application

10.1.1.11.5 Poland: Spinal Cord Stimulation Device for Chronic Pain Market, by End User

10.1.1.12 Slovakia

10.1.1.12.1 Overview

10.1.1.12.2 Slovakia: Spinal Cord Stimulation Device for Chronic Pain Market Revenue and Forecast to 2030 (US$ Mn)

10.1.1.12.3 Slovakia: Spinal Cord Stimulation Device for Chronic Pain Market, by Product Type

10.1.1.12.4 Slovakia: Spinal Cord Stimulation Device for Chronic Pain Market, by Application

10.1.1.12.5 Slovakia: Spinal Cord Stimulation Device for Chronic Pain Market, by End User

10.1.1.13 Czech Republic

10.1.1.13.1 Overview

10.1.1.13.2 Czech Republic: Spinal Cord Stimulation Device for Chronic Pain Market Revenue and Forecast to 2030 (US$ Mn)

10.1.1.13.3 Czech Republic: Spinal Cord Stimulation Device for Chronic Pain Market, by Product Type

10.1.1.13.4 Czech Republic: Spinal Cord Stimulation Device for Chronic Pain Market, by Application

10.1.1.13.5 Czech Republic: Spinal Cord Stimulation Device for Chronic Pain Market, by End User

10.1.1.14 Greece

10.1.1.14.1 Overview

10.1.1.14.2 Greece: Spinal Cord Stimulation Device for Chronic Pain Market Revenue and Forecast to 2030 (US$ Mn)

10.1.1.14.3 Greece: Spinal Cord Stimulation Device for Chronic Pain Market, by Product Type

10.1.1.14.4 Greece: Spinal Cord Stimulation Device for Chronic Pain Market, by Application

10.1.1.14.5 Greece: Spinal Cord Stimulation Device for Chronic Pain Market, by End User

10.1.1.15 Ireland

10.1.1.15.1 Overview

10.1.1.15.2 Ireland: Spinal Cord Stimulation Device for Chronic Pain Market Revenue and Forecast to 2030 (US$ Mn)

10.1.1.15.3 Ireland: Spinal Cord Stimulation Device for Chronic Pain Market, by Product Type

10.1.1.15.4 Ireland: Spinal Cord Stimulation Device for Chronic Pain Market, by Application

10.1.1.15.5 Ireland: Spinal Cord Stimulation Device for Chronic Pain Market, by End User

10.1.1.16 Rest of Europe

10.1.1.16.1 Overview

10.1.1.16.2 Rest of Europe: Spinal Cord Stimulation Device for Chronic Pain Market Revenue and Forecast to 2030 (US$ Mn)

10.1.1.16.3 Rest of Europe: Spinal Cord Stimulation Device for Chronic Pain Market, by Product Type

10.1.1.16.4 Rest of Europe: Spinal Cord Stimulation Device for Chronic Pain Market, by Application

10.1.1.16.5 Rest of Europe: Spinal Cord Stimulation Device for Chronic Pain Market, by End User

11. Industry Landscape

11.1 Overview

11.2 Growth Strategies Done by the Companies in the Market (%)

11.3 Organic Developments

11.3.1 Overview

11.4 Inorganic Developments

11.4.1 Overview

12. Company Profiles

12.1 Boston Scientific Corp

12.1.1 Key Facts

12.1.2 Business Description

12.1.3 Products and Services

12.1.4 Financial Overview

12.1.5 SWOT Analysis

12.1.6 Key Developments

12.2 Abbott Laboratories

12.2.1 Key Facts

12.2.2 Business Description

12.2.3 Products and Services

12.2.4 Financial Overview

12.2.5 SWOT Analysis

12.2.6 Key Developments

12.3 Medtronic Plc

12.3.1 Key Facts

12.3.2 Business Description

12.3.3 Products and Services

12.3.4 Financial Overview

12.3.5 SWOT Analysis

12.3.6 Key Developments

12.4 Biotronik SE & Co KG

12.4.1 Key Facts

12.4.2 Business Description

12.4.3 Products and Services

12.4.4 Financial Overview

12.4.5 SWOT Analysis

12.4.6 Key Developments

12.5 Nevro Corp

12.5.1 Key Facts

12.5.2 Business Description

12.5.3 Products and Services

12.5.4 Financial Overview

12.5.5 SWOT Analysis

12.5.6 Key Developments

12.6 Cirtec Medical Corp

12.6.1 Key Facts

12.6.2 Business Description

12.6.3 Products and Services

12.6.4 Financial Overview

12.6.5 SWOT Analysis

12.6.6 Key Developments

12.7 Synapse Biomedical Inc

12.7.1 Key Facts

12.7.2 Business Description

12.7.3 Products and Services

12.7.4 Financial Overview

12.7.5 SWOT Analysis

12.7.6 Key Developments

13. Appendix

13.1 About The Insight Partners

13.2 Glossary of Terms

List of Tables

Table 1. Europe Spinal Cord Stimulation Device for Chronic Pain Market Segmentation

Table 2. Germany: Spinal Cord Stimulation Device for Chronic Pain Market Revenue and Forecast to 2030 (US$ Mn) - Product Type

Table 3. Germany: Spinal Cord Stimulation Device for Chronic Pain Market Revenue and Forecast to 2030 (US$ Mn) - Application

Table 4. Germany: Spinal Cord Stimulation Device for Chronic Pain Market Revenue and Forecast to 2030 (US$ Mn) - End User

Table 5. France: Spinal Cord Stimulation Device for Chronic Pain Market Revenue and Forecast to 2030 (US$ Mn) - Product Type

Table 6. France: Spinal Cord Stimulation Device for Chronic Pain Market Revenue and Forecast to 2030 (US$ Mn) - Application

Table 7. France: Spinal Cord Stimulation Device for Chronic Pain Market Revenue and Forecast to 2030 (US$ Mn) - End User

Table 8. Italy: Spinal Cord Stimulation Device for Chronic Pain Market Revenue and Forecast to 2030 (US$ Mn) - Product Type

Table 9. Italy: Spinal Cord Stimulation Device for Chronic Pain Market Revenue and Forecast to 2030 (US$ Mn) - Application

Table 10. Italy: Spinal Cord Stimulation Device for Chronic Pain Market Revenue and Forecast to 2030 (US$ Mn) - End User

Table 11. Spain: Spinal Cord Stimulation Device for Chronic Pain Market Revenue and Forecast to 2030 (US$ Mn) - Product Type

Table 12. Spain: Spinal Cord Stimulation Device for Chronic Pain Market Revenue and Forecast to 2030 (US$ Mn) - Application

Table 13. Spain: Spinal Cord Stimulation Device for Chronic Pain Market Revenue and Forecast to 2030 (US$ Mn) - End User

Table 14. United Kingdom: Spinal Cord Stimulation Device for Chronic Pain Market Revenue and Forecast to 2030 (US$ Mn) - Product Type

Table 15. United Kingdom: Spinal Cord Stimulation Device for Chronic Pain Market Revenue and Forecast to 2030 (US$ Mn) - Application

Table 16. United Kingdom: Spinal Cord Stimulation Device for Chronic Pain Market Revenue and Forecast to 2030 (US$ Mn) - End User

Table 17. Switzerland: Spinal Cord Stimulation Device for Chronic Pain Market Revenue and Forecast to 2030 (US$ Mn) - Product Type

Table 18. Switzerland: Spinal Cord Stimulation Device for Chronic Pain Market Revenue and Forecast to 2030 (US$ Mn) - Application

Table 19. Switzerland: Spinal Cord Stimulation Device for Chronic Pain Market Revenue and Forecast to 2030 (US$ Mn) - End User

Table 20. Netherlands: Spinal Cord Stimulation Device for Chronic Pain Market Revenue and Forecast to 2030 (US$ Mn) - Product Type

Table 21. Netherlands: Spinal Cord Stimulation Device for Chronic Pain Market Revenue and Forecast to 2030 (US$ Mn) - Application

Table 22. Netherlands: Spinal Cord Stimulation Device for Chronic Pain Market Revenue and Forecast to 2030 (US$ Mn) - End User

Table 23. Sweden: Spinal Cord Stimulation Device for Chronic Pain Market Revenue and Forecast to 2030 (US$ Mn) - Product Type

Table 24. Sweden: Spinal Cord Stimulation Device for Chronic Pain Market Revenue and Forecast to 2030 (US$ Mn) - Application

Table 25. Sweden: Spinal Cord Stimulation Device for Chronic Pain Market Revenue and Forecast to 2030 (US$ Mn) - End User

Table 26. Belgium: Spinal Cord Stimulation Device for Chronic Pain Market Revenue and Forecast to 2030 (US$ Mn) - Product Type

Table 27. Belgium: Spinal Cord Stimulation Device for Chronic Pain Market Revenue and Forecast to 2030 (US$ Mn) - Application

Table 28. Belgium: Spinal Cord Stimulation Device for Chronic Pain Market Revenue and Forecast to 2030 (US$ Mn) - End User

Table 29. Poland: Spinal Cord Stimulation Device for Chronic Pain Market Revenue and Forecast to 2030 (US$ Mn) - Product Type

Table 30. Poland: Spinal Cord Stimulation Device for Chronic Pain Market Revenue and Forecast to 2030 (US$ Mn) - Application

Table 31. Poland: Spinal Cord Stimulation Device for Chronic Pain Market Revenue and Forecast to 2030 (US$ Mn) - End User

Table 32. Slovakia: Spinal Cord Stimulation Device for Chronic Pain Market Revenue and Forecast to 2030 (US$ Mn) - Product Type

Table 33. Slovakia: Spinal Cord Stimulation Device for Chronic Pain Market Revenue and Forecast to 2030 (US$ Mn) - Application

Table 34. Slovakia: Spinal Cord Stimulation Device for Chronic Pain Market Revenue and Forecast to 2030 (US$ Mn) - End User

Table 35. Czech Republic: Spinal Cord Stimulation Device for Chronic Pain Market Revenue and Forecast to 2030 (US$ Mn) - Product Type

Table 36. Czech Republic: Spinal Cord Stimulation Device for Chronic Pain Market Revenue and Forecast to 2030 (US$ Mn) - Application

Table 37. Czech Republic: Spinal Cord Stimulation Device for Chronic Pain Market Revenue and Forecast to 2030 (US$ Mn) - End User

Table 38. Greece: Spinal Cord Stimulation Device for Chronic Pain Market Revenue and Forecast to 2030 (US$ Mn) - Product Type

Table 39. Greece: Spinal Cord Stimulation Device for Chronic Pain Market Revenue and Forecast to 2030 (US$ Mn) - Application

Table 40. Greece: Spinal Cord Stimulation Device for Chronic Pain Market Revenue and Forecast to 2030 (US$ Mn) - End User

Table 41. Ireland: Spinal Cord Stimulation Device for Chronic Pain Market Revenue and Forecast to 2030 (US$ Mn) - Product Type

Table 42. Ireland: Spinal Cord Stimulation Device for Chronic Pain Market Revenue and Forecast to 2030 (US$ Mn) - Application

Table 43. Ireland: Spinal Cord Stimulation Device for Chronic Pain Market Revenue and Forecast to 2030 (US$ Mn) - End User

Table 44. Rest of Europe: Spinal Cord Stimulation Device for Chronic Pain Market Revenue and Forecast to 2030 (US$ Mn) - Product Type

Table 45. Rest of Europe: Spinal Cord Stimulation Device for Chronic Pain Market Revenue and Forecast to 2030 (US$ Mn) - Application

Table 46. Rest of Europe: Spinal Cord Stimulation Device for Chronic Pain Market Revenue and Forecast to 2030 (US$ Mn) - End User

Table 47. Organic Developments Done By Companies

Table 48. Inorganic Developments Done By Companies

Table 49. Glossary of Terms

List of Figures

Figure 1. Europe Spinal Cord Stimulation Device for Chronic Pain Market, by Country

Figure 2. Key Insights

Figure 3. Europe Spinal Cord Stimulation Device Market for Chronic Pain: Company Share Analysis

Figure 4. Europe Spinal Cord Stimulation Device Market for Chronic Pain: Pricing Analysis

Figure 5. Europe Spinal Cord Stimulation Device for Chronic Pain Market- Key Industry Dynamics

Figure 6. Europe Spinal Cord Stimulation Device for Chronic Pain Market: Impact Analysis of Drivers and Restraints

Figure 7. Europe Spinal Cord Stimulation Device for Chronic Pain Market - Revenue Forecast and Analysis - 2020-2030

Figure 8. Europe Spinal Cord Stimulation Device for Chronic Pain Market Revenue Share, by Product Type, 2022 & 2030 (%)

Figure 9. Rechargeable: Europe Spinal Cord Stimulation Device for Chronic Pain Market - Revenue and Forecast to 2030 (US$ Million)

Figure 10. Non-Rechargeable: Europe Spinal Cord Stimulation Device for Chronic Pain Market - Revenue and Forecast to 2030 (US$ Million)

Figure 11. Europe Spinal Cord Stimulation Device for Chronic Pain Market Revenue Share, by Application (2022 and 2030)

Figure 12. Failed Back Syndrome: Europe Spinal Cord Stimulation Device for Chronic Pain Market - Revenue and Forecast to 2030 (US$ Million)

Figure 13. Complex Regional Pain Syndrome: Europe Spinal Cord Stimulation Device for Chronic Pain Market - Revenue and Forecast to 2030 (US$ Million)

Figure 14. Degenerative Disk Disease: Europe Spinal Cord Stimulation Device for Chronic Pain Market - Revenue and Forecast to 2030 (US$ Million)

Figure 15. Others: Europe Spinal Cord Stimulation Device for Chronic Pain Market - Revenue and Forecast to 2030 (US$ Million)

Figure 16. Europe Spinal Cord Stimulation Device for Chronic Pain Market Revenue Share, by End User (2022 and 2030)

Figure 17. Hospitals: Europe Spinal Cord Stimulation Device for Chronic Pain Market - Revenue and Forecast to 2030 (US$ Million)

Figure 18. Ambulatory Surgery Centers (ASCs): Europe Spinal Cord Stimulation Device for Chronic Pain Market - Revenue and Forecast to 2030 (US$ Million)

Figure 19. Others: Europe Spinal Cord Stimulation Device for Chronic Pain Market - Revenue and Forecast to 2030 (US$ Million)

Figure 20. Europe Spinal Cord Stimulation Device for Chronic Pain Market, Country 2022 ($Mn)

Figure 21. Europe: Spinal Cord Stimulation Device for Chronic Pain Market, By Key Countries, 2022 And 2030 (%)

Figure 22. Germany: Spinal Cord Stimulation Device for Chronic Pain Market Revenue and Forecast to 2030 (US$ Mn)

Figure 23. France: Spinal Cord Stimulation Device for Chronic Pain Market Revenue and Forecast to 2030 (US$ Mn)

Figure 24. Italy: Spinal Cord Stimulation Device for Chronic Pain Market Revenue and Forecast to 2030 (US$ Mn)

Figure 25. Spain: Spinal Cord Stimulation Device for Chronic Pain Market Revenue and Forecast to 2030 (US$ Mn)

Figure 26. United Kingdom: Spinal Cord Stimulation Device for Chronic Pain Market Revenue and Forecast to 2030 (US$ Mn)

Figure 27. Switzerland: Spinal Cord Stimulation Device for Chronic Pain Market Revenue and Forecast to 2030 (US$ Mn)

Figure 28. Netherlands: Spinal Cord Stimulation Device for Chronic Pain Market Revenue and Forecast to 2030 (US$ Mn)

Figure 29. Sweden: Spinal Cord Stimulation Device for Chronic Pain Market Revenue and Forecast to 2030 (US$ Mn)

Figure 30. Belgium: Spinal Cord Stimulation Device for Chronic Pain Market Revenue and Forecast to 2030 (US$ Mn)

Figure 31. Poland: Spinal Cord Stimulation Device for Chronic Pain Market Revenue and Forecast to 2030 (US$ Mn)

Figure 32. Slovakia: Spinal Cord Stimulation Device for Chronic Pain Market Revenue and Forecast to 2030 (US$ Mn)

Figure 33. Czech Republic: Spinal Cord Stimulation Device for Chronic Pain Market Revenue and Forecast to 2030 (US$ Mn)

Figure 34. Greece: Spinal Cord Stimulation Device for Chronic Pain Market Revenue and Forecast to 2030 (US$ Mn)

Figure 35. Ireland: Spinal Cord Stimulation Device for Chronic Pain Market Revenue and Forecast to 2030 (US$ Mn)

Figure 36. Rest of Europe: Spinal Cord Stimulation Device for Chronic Pain Market Revenue and Forecast to 2030 (US$ Mn)

Figure 37. Growth Strategies Done by the Companies in the Market (%)

1. Boston Scientific Corp
2. Abbott Laboratories
3. Medtronic Plc
4. Biotronik SE & Co KG
5. Nevro Corp
6. Cirtec Medical Corp
7. Synapse Biomedical Inc

  • Save and reduce time carrying out entry-level research by identifying the growth, size, leading players, and segments in the Europe spinal cord stimulation device for chronic pain market.
  • Highlights key business priorities in order to assist companies to realign their business strategies.
  • The key findings and recommendations highlight crucial progressive industry trends in Europe spinal cord stimulation device for chronic pain market, thereby allowing players across the value chain to develop effective long-term strategies.
  • Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.
  • Scrutinize in-depth Europe market trends and outlook coupled with the factors driving the market, as well as those hindering it.
  • Enhance the decision-making process by understanding the strategies that underpin security interest with respect to client products, segmentation, pricing, and distribution.
Report Code
Full Name
Country Name
Email Id
Phone Number
Job Title
Company
Requirement

Note : Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.


Purchase Options
Single User License
$3550
$2840
Site License
$4550
$3640
Enterprise License
$5550
$4440